+91-8668442535
Home / Healthcare / Clinical T

Clinical Trial Recruitment in Respiratory Market By Service Type (Patient Recruitment & Registry Services, Patient Retention Services, Others) By Phase (Phase I, Phase II, Phase III, Phase IV) By Age Group (Child (Birth-17 Years), Adult (18 - 64 Years), Older Adults (65 Years+) - Growth, Future Prospects & Competitive Analysis, 2016 – 2028

About this report

The global clinical trial recruitment in respiratory market report explores the critical analysis of the clinical trial recruitment in respiratory industry using the key parameters. The report consists of investment strategies, the need for investments in the clinical trial recruitment in respiratory industry, and the multiple benefits for the investors. Importantly, this report sets out major changes in the global technical regulations for the clinical trial recruitment in respiratory industry and how economic and non-economic barriers are helping the clinical trial recruitment in respiratory market grow. Moreover, the report analyzes the global, regional, and country-level historic and forecasted market size. The report also provides a comprehensive analysis of key investment propositions, demand and supply gap, competitors positioning, STAR analysis, SRC analysis, and Tornado analysis. Key technological developments and other analyses such as porter's five forces analysis, PESTEL analysis, value chain analysis, etc.

clinical-trial-recruitment-in-respiratory-market

Key Highlights of the report

How are the major segments performing in the clinical trial recruitment in respiratory market?

  • In 2021, the patient recruitment & registry services held the highest revenue share in clinical trial recruitment in respiratory market. The growth is majorly due to the rising adoption of digital technologies in enrolment services.
  • In 2021, phase III category dominated the market with significant revenue share in the market. This growth can be ascribed to the fact that phase III clinical studies are the costliest and include a large number of patients.
  • In 2021, adult (18 - 64 Years) category held the highest market share of global clinical trial recruitment in respiratory market. The growth is majorly due to the participation of a higher number of participants in clinical studies as well as the age group is seeing an increase in the prevalence of health issues.

Which region dominated the clinical trial recruitment in respiratory market?

In 2021, North America led the global clinical trial recruitment in respiratory market due to the significant number of clinical trials being undertaken in the region. Furthermore, major R&D expenditures and government backing for clinical trials are driving the market growth over the forecast period.

What is the competitive environment of the clinical trial recruitment in respiratory market?

The clinical trial recruitment in respiratory industry's competitive environment provides information on the entire economic profit made by suppliers and businesses, the sales and revenues created in this sector, the clinical trial recruitment in respiratory market share globally, the business organization summary, the introduction of new products, and the opportunities for the clinical trial recruitment in respiratory market. In addition, the primary expansion strategies of clinical trial organization for reaching out to consumers include a well-structured and efficient supply chain and an expanded hospitals network.

Executive Summary

Why is patient recruitment important in clinical trials?

Recruitment and enrolment take a lot of time; therefore, they frequently cause trial deadlines to be missed. According to the National Center for Biotechnology Information, insufficient or late patient enrolment into randomised clinical trials has major repercussions. The trial length may need to be increased, which may increase resource utilisation and expenditures. Long trials delay the public's access to potentially useful therapies. Adequate sample size is also required for the study's integrity and validity. If the sample size is not met, the likelihood of making a type II mistake increases. The experiment may have to be cancelled, and the findings may not be published. Improving patient recruitment is one-way pharmaceutical firms might prevent such costly delays and shorten the time it takes for new treatments to reach the market. The medication development process comprises clinical studies that take place across four phases, each with a particular goal.

Which are the key investments by the clinical trial recruitment in respiratory market players?

Leading players operating in the clinical trial recruitment in respiratory market are focusing on expansion in production capacities for storage and retrieval systems. Apart from this, players are concentrating on strategic mergers and acquisitions, collaborations and creating awareness among the businesses via various advertisement campaigns to help the manufacturers to promote the usage of clinical trial recruitment in respiratory in the industry, which further helps to expand their customer base in global clinical trial recruitment in respiratory market to gain a competitive edge.

Some major players in the clinical trial recruitment in respiratory market are Antidote, Clara Health, Clariness, BBK Worldwide, Worldwide Clinical Trials, Clinical Site Services (CCSi), IQVIA, PPD Inc., Veristat, and Elligo Health Research.

What are the major driving factors for the clinical trial recruitment in respiratory market?

The growing incidence of clinical trials and the fast expansion of the medical and pharmaceutical sectors, are some major factors driving the growth of global clinical trial recruitment in respiratory market. Moreover, clinical trials are carried out to gather information on the efficacy and safety of new medical devices and drug development. As the number of individuals required for clinical trials grows due to regulatory and safety concerns, trends toward longer and larger studies emerge, boosting the demand for patient recruiting services in the market. Also, the biopharmaceutical industry's change in attention to creating vaccines and medicines in response to COVID-19 has had unforeseen implications that may disrupt clinical trials for other illnesses. Such factors are responsible for fuelling the growth of clinical trial recruitment in respiratory market in the next few years.

What are the major risks for the clinical trial recruitment in respiratory market?

The high cost of conducting clinical trials and long approval times hinder market growth. Moreover, strict regulatory policies for patient enrolment and lack of expertise in clinical research, are some other factors which hampers the growth of global clinical trial recruitment in respiratory market.

Which is the key application in the clinical trial recruitment in respiratory market?

Patient retention services are expected to grow at significant CAGR over the forecast period. Technology is used for a variety of outreach strategies, including online health groups, social media, and digital marketing. These initiatives are quickly changing the clinical trial environment. Because these people are actively engaged online, sponsors, recruiting suppliers, advertising, and others may see behavioural trends. This is critical if organisations are employing online outreach to help with retention and want to know where to spend their money to reach the intended patient demographics.

How is the clinical trial recruitment in respiratory market performing in regions?

Asia-Pacific dominated with the highest revenue share in global Clinical Trial Recruitment in Respiratory market owing to the rising number of educational institutions in the emerging economies such as China and India. Furthermore, the growing investment by public and private organizations to encourage more student enrolment in schools further drives the market in this region. On the other hand, North America is expected to grow at a significant CAGR over the forecast period due to increasing consumer spending on child education across the region.

What is the regulatory landscape for the clinical trial recruitment in respiratory market?

Understanding the regulatory requirements for conducting, completing, and producing quality clinical trial data is critical before planning a clinical study. Distinct authorities have different standards, varying depending on the study type. Many researchers, for example, find patient recruitment in uncommon illnesses to be a nightmare, thus many regulators, such as the FDA, explore adaptive approaches in recruiting a few patients and extrapolating the safety findings. Guidelines for the design of clinical trials for small populations have been developed by the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA). Regulators are willing to consider using various methodology and evidence sources to improve the overall evidence base.

What is the market size of clinical trial recruitment in respiratory regarding value?

The global clinical trial recruitment in respiratory market is anticipated to grow at a significant CAGR of XX% during the forecast period. The global clinical trial recruitment in respiratory industry was estimated to be worth USD XX billion in 2021 and was expected to be worth USD XX billion by 2028.

What are the major players planning for the future of the clinical trial recruitment in respiratory market?

Growing regional existence and investment in downstream applications are anticipated to deliver a competitive edge in the market. For instance, in September 2021, Syneos Health collaborated with Ride Health, a provider of non-emergency medical transportation (NEMT) for clinical trial participants, to improve Syneos Health's clinical trial recruiting and retention service by offering transportation facilities to participants.

Segmentation of Global Clinical Trial Recruitment in Respiratory Market-

Global Clinical Trial Recruitment in Respiratory Market – By Service Type

  • Patient Recruitment & Registry Services
  • Patient Retention Services
  • Others

Global Clinical Trial Recruitment in Respiratory Market – By Phase

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Global Clinical Trial Recruitment in Respiratory Market – By Age Group

  • Child (Birth-17 Years)
  • Adult (18 - 64 Years)
  • Older Adults (65 Years+)

Global Clinical Trial Recruitment in Respiratory Market – By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-east Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East and Africa

Frequently asked questions about the global clinical trial recruitment in respiratory market

The COVID-19 outbreak temporarily hampered clinical research progress in 2020, owing to the government's shutdown, which negatively influenced the market growth.

North America accounted for the major global clinical trial recruitment in respiratory market revenue.

The major drivers responsible for the market's growth include

The patient recruitment & registry services segment had a major share in the global market in 2021.

The phase III segment had a major share in the global market in 2021.

Clinical Trial Recruitment in Respiratory Market Scope

Report Attribute Details
Market Value in 2021 USD XX billion
Market Value in 2028 USD XX billion
CAGR XX%
Benchmarking Year 2021
Past data 2016 – 2021
Forecast period 2022 – 2028
Choose License Type
Trusted By
Godaddy
Published Date:  Oct 2022
Category:  Healthcare
Report ID:   60742
Report Format:   PDF
Pages:   140
Rating:    4.2 (60)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
+91-8668442535
24/7 Research Support